Torrent Pharmaceuticals has reported results for third quarter ended December 31, 2023 (Q3FY24).
The company has reported 26.92% rise in net profit at Rs 297 crore for the third quarter ended December 31, 2023 as compared to Rs 234 crore for the same quarter in the previous year. Total income of the company increased by 9.43% at Rs 2112 crore for Q3FY24 as compared Rs 1930 crore for corresponding quarter of the previous year.
On consolidated basis, the company reported 51.71% rise in its net profit at Rs 443 crore for Q3FY24 as compared to Rs 292 crore for the same quarter in the previous year. Total income of the company increased by 8.79% at Rs 2699 crore for Q3FY24 as compared Rs 2481 crore for corresponding quarter of the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1502.30 |
Dr. Reddys Lab | 6198.90 |
Cipla | 1402.20 |
Zydus Lifesciences | 957.00 |
Lupin | 1645.00 |
View more.. |